Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases

15 Jun 2017

Abstract excerpt

There is currently an unmet need for better biomarkers across the spectrum of renal diseases. In this paper, we revisit the role of Beta 2 microglobulin (β2M) as a biomarker in patients with Chronic Kidney Disease (CKD) and End Stage Renal Disease (ESRD). Prior to reviewing the numerous clinical studies in the area, we describe the basic biology of β2M, focusing in particular on its role in maintaining the serum...

Topics

Join the communities discussing this publication.

Chronic Kidney Disease and Diabetes
Dialysis and Renal Disease Management
Renal Diseases and Glomerulopathies

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 28664159
DOI: 10.3389/fmed.2017.00073

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney DiseasesPMID 28664159Read ↗

Predicting the protein composition of human urine in normal and pathological states: Quantitative description based on Dent1 disease (CLCN5 mutation).Semantic proximity Read ↗

Proteomics: Progress and Promise of High-Throughput Proteomics in Chronic Kidney DiseaseSemantic proximity Read ↗

Insights into Renal Protein Handling Through GWAS of the Human Urine ProteomeSemantic proximity Read ↗

Bias-corrected serum creatinine from UK Biobank electronic medical records generates an important data resource for kidney function trajectoriesSemantic proximity Read ↗

Mayo Clinic Consensus Report on Membranous Nephropathy: Proposal for a Novel Classification.Semantic proximity Read ↗

Albuminuria Changes as a surrogate endpoint in <i>Apolipoprotein L1</i> Mediated Kidney Disease in Vanderbilt BioVU and the Million Veteran ProgramSemantic proximity Read ↗

Functional Renal Reserve-Guided Personalized Renoprotection in Chronic Kidney Disease: Extending the KDIGO CGA FrameworkSemantic proximity Read ↗

Translational science in chronic kidney disease.Semantic proximity Read ↗

Trajectories of kidney function in diabetes: a clinicopathological update.Semantic proximity Read ↗

Proteomics of CKD progression in the chronic renal insufficiency cohortSemantic proximity Read ↗

Utility of renal biopsy in the clinical management of renal disease.Semantic proximity Read ↗

Cardiovascular disease protein biomarkers are associated with kidney function: the Framingham Heart StudySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.